mybacs
PrivateLast Round
Series A
Oct 30, 2023
Total Funding Raised
$5.94M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
mybacs operates in Healthcare & Life Sciences and is based in Zug. Its latest recorded funding round was a Series A round in October 2023.
mybacs is a consumer non-durables company that develops and markets synbiotic dietary supplements with a focus on intestinal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Subscription Commerce, E-commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
mybacs Comparables
Compare mybacs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cuure | 83% | |
| DIJO | 81% | |
| Pendulum Therapeutics | 80% |
For institutional investors. Book with your work email.
mybacs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 30, 2023 | ||||
| Seed | Jul 15, 2020 | ||||
| Seed | Aug 29, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
mybacs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Founders Capital | Series A, Seed |
| naturalX Health Ventures | Series A |
| Joyance Partners | Series A, Seed |
| WENVEST Capital | Series A |
| SevenVentures | Series A, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 23, 2026
Grew 17% QoQ, from 53 to 62 employees.
- Aug 21, 2026
Monthly visitors grew 71% MoM, reaching 99.4K.
For institutional investors. Book with your work email.
mybacs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about mybacs's valuation, stock price, and market status.
Is mybacs a public or private company?
mybacs is a private company.
What is the current stock price of mybacs?
mybacs is a private company, so its shares have no public market price. Caplight tracks mybacs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is mybacs worth (valuation)?
Valuation information for mybacs is not publicly available.
Can I buy mybacs stock?
mybacs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was mybacs's last funding round?
mybacs's most recent funding round was Series A on October 30, 2023.
Who are the main investors in mybacs?
Key investors in mybacs include Global Founders Capital, naturalX Health Ventures, SevenVentures.
Will mybacs IPO soon?
No public IPO plans have been announced for mybacs.
How can I track mybacs secondary market activity?
Caplight tracks bids, offers, and trades in mybacs's shares on secondary markets.